Robert E Ormond

Title: Innovations of Robert E. Ormond in Antiparasitic Compounds

Introduction

Robert E. Ormond, an accomplished inventor based in Edison, NJ, has made significant contributions to the field of pharmaceuticals with a total of four patents. His work primarily focuses on the development of novel antiparasitic compounds derived from unique microorganisms.

Latest Patents

Ormond's latest patents include groundbreaking innovations involving a strain of Streptomyces for producing antiparasitic compounds. His first notable patent describes the fermentation of a previously undescribed microorganism, Streptomyces avermitilis, which generates compounds generically identified as C-076. These compounds exhibit substantial parasiticidal activity and can be isolated through solvent extraction and chromatographic fractionation techniques. These compounds are valuable in preventing and curing parasitic infections in animals through oral or parenteral administration.

His second recent patent involves 22-hydroxy derivatives of the C-076 compounds. Here, the normally substituted 22-position is modified with a hydroxy group. The derivatives are isolated from the C-076 fermentation broth and showcase potent anthelmintic, insecticidal, and acaricidal activities, thus broadening their application in pharmaceutical compositions.

Career Highlights

Robert E. Ormond is affiliated with Merck & Company, Inc., a leading global healthcare company. His work at Merck focuses on research and development of innovative pharmaceutical solutions to combat various parasitic infections, showcasing his strong dedication to improving animal and human health.

Collaborations

Throughout his career, Ormond has collaborated with esteemed colleagues such as Thomas W. Miller and George E. Albers-Schonberg. These partnerships have played a vital role in fostering innovative ideas and enhancing the quality of research outcomes in their respective fields.

Conclusion

Robert E. Ormond stands out as a prominent inventor whose work has significantly influenced the development of antiparasitic compounds. His innovative approach and collaborations with notable colleagues at Merck & Company, Inc. have resulted in patents that hold great promise for the prevention and treatment of parasitic infections. As the field of pharmaceuticals continues to evolve, his contributions remain vital in advancing healthcare solutions.